Search results
Found 6785 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Return to school sees improvement in children's mental health
Coronavirus COVID-19 General Research
17 November 2020
Mental health difficulties in children increased during the first national lockdown (between March and June 2020), but have decreased since.
Interferon-b trial shows positive results
Clinical Trials Coronavirus COVID-19 General Research
16 November 2020
A trial of a new inhaled antiviral drug for COVID-19 has shown positive results and the drug is now moving into a larger international phase 3 trial of hospitalised patients.
UNIQ+ 2021 – Project Supervisors Needed
13 November 2020
Oxford’s vaccine research and development boosted by donation from Wafic Saïd
Coronavirus COVID-19 General
12 November 2020
The University of Oxford has secured a critical professorship in vaccinology for the future following a gift of £3.33 million from the Saïd family. The gift will enable Professor Sarah Gilbert, the inaugural post holder, to continue her ground-breaking research in the field, while also helping to ensure that Oxford remains at the forefront of vaccine development for generations to come.
Oxford University and PHE confirm high-sensitivity of Lateral Flow Tests following extensive clinical evaluation
Coronavirus COVID-19 General Research
12 November 2020
Extensive clinical evaluation from Public Health England and the University of Oxford show Lateral Flow Tests are accurate and sensitive enough to be used in the community, including for asymptomatic people.
Oxford ramps up COVID-19 testing capability
Coronavirus COVID-19 General Research
10 November 2020
The University of Oxford has joined forces with Thermo Fisher Scientific, the world leader in serving science, to ramp up the university’s capacity to deliver COVID-19 testing data.
HIV-1 recombinants: The challenges of increasing genetic diversity
General Research
10 November 2020
Dr Joris Hemelaar, University Research Lecturer and expert in maternal HIV infection at the Nuffield Department of Women's & Reproductive Health, published a new article: "Global and regional epidemiology of HIV-1 recombinants in 1990-2015" in the Lancet HIV.
Almost 20% of COVID-19 patients receive psychiatric diagnosis within 90 days
Coronavirus COVID-19 General Research
10 November 2020
New study suggests that having COVID-19 increases a person’s risk of developing psychiatric disorders, and that having a psychiatric disorder increases the chance of getting COVID-19. The study, published in The Lancet Psychiatry, used the TriNetX electronic health records of 69 million people in the USA including over 62,000 cases of COVID-19.
Virtual wards: caring for COVID-19 patients at home could save lives
Coronavirus COVID-19 General Research
9 November 2020
Odds and evens: a strategy for safely exiting lockdown 2
Coronavirus COVID-19 General Research
9 November 2020
COVID antibodies wane within months, healthcare workers study shows
Coronavirus COVID-19 Research
6 November 2020
Antibodies to COVID-19 fall by half in less than 90 days, and antibody levels peak lower and fall faster in younger adults, an ongoing study of staff at Oxford University Hospitals NHS Foundation Trust has revealed.
Bodleian Libraries update - Nov 2020
6 November 2020
Analysis shows that funding gender equity incentives can work
Athena Swan General Research
4 November 2020
A paper by Oxford BRC-supported researchers says that linking research funding to Athena SWAN gender equality action plans has been associated with a rise in the number of women in mid-level leadership positions and the proportion of funding going to women.
New research confirms obesity is a cause of kidney disease
General Research
4 November 2020
Scientists at the University of Oxford have discovered that obesity can increase the chances of someone developing kidney disease.
BioEscalator’s resident biotech Base Genomics acquired by Exact Sciences
General Innovation
4 November 2020
Oxford Sciences Innovation (OSI) recently announced the acquisition of its portfolio company, Base Genomics, by US-based early cancer diagnostic leaders, Exact Sciences, for $410m. The partnership will enable Base Genomics to significantly accelerate its clinical and commercial development here in Oxford, potentially unlocking a new era of preventative medicine and improved patient outcomes.